Without additional funding from Congress, the U.S. cannot secure sufficient COVID-19 vaccine boosters and variant-specific vaccines for all Americans; reimburse providers to test, treat and vaccinate the uninsured; provide monoclonal antibody therapies to states; or sustain testing capacity, among other actions, according to a White House announcement today. 

“Earlier this month, President Biden laid out a comprehensive plan to ensure that the country can continue to move forward safely and remain prepared to fight new variants and future surges of the virus. And the Administration has been clear that we need Congress to provide additional resources, including $22.5 billion in immediate emergency funding. Inaction will set us back in this fight, leave us less prepared, and cost us more lives,” the fact sheet states.
 

Related News Articles

Headline
The federal government shut down Oct. 1 following a failed Senate vote on the House-passed continuing resolution to fund the government by midnight Sept. 30.…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The AHA Sept. 24 expressed support for the Medical Student Education Authorization Act (H.R. 5428), legislation introduced in the House Sept. 17 that would…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The AHA expressed support Sept. 22 to House and Senate sponsors of the Medicare Advantage Prompt Pay Act (H.R. 5454/S. 2879), legislation that would apply a…